ARIKO GROUP Healthcare Affiliate
We extend the group's technology and operating experience into healthcare to create new value in pharmaceuticals and biotechnology.
Building on pharmaceutical wholesale distribution to medical institutions and pharmacies nationwide, we are expanding into manufacturing, health products, and biotechnology R&D.
As ARIKO GROUP's healthcare affiliate, we build a dependable supply network and a rigorous quality-management system.

We extend the group's technology and operating experience into healthcare to create new value in pharmaceuticals and biotechnology.
We identify the needs of medical institutions and pharmacies and supply essential medicines safely and promptly.
Our distribution foundation supports step-by-step growth into pharmaceutical manufacturing, health products, and biotechnology R&D.
CEO Myeong Chi-min shares the commitment to protect human health through transparency and origin traceability.
Medicine is a product of trust directly connected to human life.
Greetings. I am Myeong Chi-min, CEO of ARIKO Pharmaceutical (Youngwon Pharmaceutical).
ARIKO Pharmaceutical began at the next destination the circular economy must reach. Can technologies that refine and restore resources extend beyond resource recycling to protecting human health? This question is the starting point of our business.
Our management philosophy is transparency and origin traceability. We believe that any product bearing the ARIKO GROUP name must allow consumers and partners to verify where its ingredients came from and what processes they underwent. This is not merely the minimum obligation required by regulation, but a standard we impose on ourselves.
We also combine our long-standing expertise in fermentation and refining with modern quality-management systems. Rather than settling for traditional pharmaceutical practices, we continuously verify and improve. Bringing a laboratory discovery closer to a real product is how we define innovation.
To our healthcare partners, distribution channels, and consumers, we make this promise: ARIKO Pharmaceutical will become a company that proves trust before anything else.
Myeong Chi-min
CEO, ARIKO Pharmaceutical (Youngwon Pharmaceutical)
From dependable distribution to future R&D, patient safety and product quality guide every step.
A stable supply network, rigorous quality management, and future growth engines support a healthier society.
We strengthen a professional system that responds to demand from medical institutions and pharmacies nationwide.
GDP principles and cold-chain operations protect quality through storage, transport, traceability, and recall.
We are advancing pharmaceutical manufacturing, health products, and biotechnology research in stages.
We are building an integrated portfolio that connects current distribution capabilities with manufacturing and research.
We supply prescription medicines to medical institutions and pharmacies while managing product quality and delivery records.
Group resources and technology support expansion into manufacturing, health products, and biotechnology research.
Our teams work as one system so R&D discoveries become trusted products through stable production and quality verification.
Oversees R&D, production, quality, and market strategy.
Validates and develops products for health and trust.
Operates a traceable quality system from raw materials to finished products.
Connects medical institutions, pharmacies, partners, and products.
Every stage from demand analysis to post-supply management is assigned clear responsibility and traceable records.
Assess product demand and delivery schedules for medical institutions and pharmacies.
Check condition, expiry dates, labeling, and storage requirements at receiving.
Maintain required temperature and humidity while managing inventory history.
Deliver products safely and promptly through validated logistics operations.
Trace supply records and perform rapid recall and corrective action when required.
Distribution experience, group collaboration, and a phased investment strategy create practical growth.
Field-based demand planning reduces stockout risk and improves supply response.
ARIKO GROUP's materials, research, design, and distribution capabilities support product development.
A stable wholesale foundation supports realistic expansion into manufacturing and R&D.

Human health and safety are the first standard in every decision.
Traceable, verifiable quality systems build lasting confidence.
We create sustainable partnerships with medical institutions, pharmacies, suppliers, and researchers.
Contact us about distribution, manufacturing, quality management, healthcare, and biotechnology R&D partnerships.